These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Pramipexole: augmentation in the treatment of depressive symptoms. Gupta S; Vincent JL; Frank B CNS Spectr; 2006 Mar; 11(3):172-5. PubMed ID: 16575373 [TBL] [Abstract][Full Text] [Related]
50. How suicidal bipolar patients are depends on how suicidal ideation is defined. Valtonen HM; Suominen K; Sokero P; Mantere O; Arvilommi P; Leppämäki S; Isometsä ET J Affect Disord; 2009 Nov; 118(1-3):48-54. PubMed ID: 19282033 [TBL] [Abstract][Full Text] [Related]
51. A preliminary study of anti-suicidal efficacy of repeated ketamine infusions in depression with suicidal ideation. Zhan Y; Zhang B; Zhou Y; Zheng W; Liu W; Wang C; Li H; Chen L; Yu L; Walter M; Li M; Li MD; Ning Y J Affect Disord; 2019 May; 251():205-212. PubMed ID: 30927581 [TBL] [Abstract][Full Text] [Related]
52. Activation of suicidal ideation with adjunctive rufinamide in bipolar disorder. Kaufman KR; Struck PJ Epilepsy Behav; 2011 Feb; 20(2):386-9. PubMed ID: 21189229 [TBL] [Abstract][Full Text] [Related]
53. Personality traits and suicidal behavior and ideation in depressed inpatients 50 years of age and older. Duberstein PR; Conwell Y; Seidlitz L; Denning DG; Cox C; Caine ED J Gerontol B Psychol Sci Soc Sci; 2000 Jan; 55(1):P18-26. PubMed ID: 10728121 [TBL] [Abstract][Full Text] [Related]
54. Trajectories of suicidal ideation over 6 months among 482 outpatients with bipolar disorder. Köhler-Forsberg O; Madsen T; Behrendt-Møller I; Sylvia L; Bowden CL; Gao K; Bobo WV; Trivedi MH; Calabrese JR; Thase M; Shelton RC; McInnis M; Tohen M; Ketter TA; Friedman ES; Deckersbach T; McElroy SL; Reilly-Harrington NA; Nierenberg AA J Affect Disord; 2017 Dec; 223():146-152. PubMed ID: 28755622 [TBL] [Abstract][Full Text] [Related]
55. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. Perlis RH; Purcell S; Fava M; Fagerness J; Rush AJ; Trivedi MH; Smoller JW Arch Gen Psychiatry; 2007 Jun; 64(6):689-97. PubMed ID: 17548750 [TBL] [Abstract][Full Text] [Related]
56. Treatment outcome in suicidal vs. non-suicidal elderly patients. Szanto K; Mulsant BH; Houck PR; Miller MD; Mazumdar S; Reynolds CF Am J Geriatr Psychiatry; 2001; 9(3):261-8. PubMed ID: 11481134 [TBL] [Abstract][Full Text] [Related]
57. Personality traits as predictors for the outcome of lithium augmentation in treatment-resistant depression. Takahashi M; Suzuki M; Muneoka K; Tsuruoka Y; Sato K; Shirayama Y Psychiatry Res; 2014 Dec; 220(3):1144-6. PubMed ID: 25453642 [TBL] [Abstract][Full Text] [Related]
58. Time Course and Predictors of Suicidal Ideation During Citalopram Treatment in the STAR*D Trial. Coughlin CG; Jakubovski E; Bloch MH J Clin Psychiatry; 2016 Oct; 77(10):e1262-e1269. PubMed ID: 27631142 [TBL] [Abstract][Full Text] [Related]
59. Depressive characteristics of adult psychiatric inpatients with a history of multiple versus one or no suicide attempts. Gibb BE; Andover MS; Miller IW Depress Anxiety; 2009; 26(6):568-74. PubMed ID: 19067437 [TBL] [Abstract][Full Text] [Related]